SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-24-000080
Filing Date
2024-05-07
Accepted
2024-05-07 17:00:41
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20240331.htm   iXBRL 10-Q 1154372
2 EX-10.1 a3312410qex101.htm EX-10.1 20042
3 EX-31.1 exhibit311q12024.htm EX-31.1 10592
4 EX-31.2 exhibit312q12024.htm EX-31.2 10579
5 EX-32.1 exhibit321q12024.htm EX-32.1 7695
  Complete submission text file 0001570562-24-000080.txt   6190163

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20240331.xsd EX-101.SCH 45293
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20240331_cal.xml EX-101.CAL 68673
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20240331_def.xml EX-101.DEF 256857
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20240331_lab.xml EX-101.LAB 561408
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20240331_pre.xml EX-101.PRE 386862
67 EXTRACTED XBRL INSTANCE DOCUMENT eols-20240331_htm.xml XML 684825
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 24923003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)